István Májer
István Májer publishes mostly in Economics and Econometrics, Genetics and General Health Professions, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Protein Degradation and Inhibitors.
- World rank
- #1,103,506 of 1,633,909 ranked researchers
- Rank in United States
- #280,818 of 358,040
- Works
- 15
- Citations
- 19
- Citations per work
- 1.3
What does István Májer research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Economics and Econometrics35% of their works
- 2Genetics10% of their works
- 3General Health Professions10% of their works
- 4Hematology5% of their works
- 5Psychiatry and Mental health5% of their works
- 6Rheumatology5% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Protein Degradation and Inhibitors
- Healthcare Systems and Practices
- Global Health Care Issues
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
Which keywords describe István Májer's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Drug Development Costs, Generic Drugs, Ageing Population, BET Bromodomains, Chronic Lymphocytic Leukemia and Diagnosis Criteria.
- Public Health
- Myelofibrosis
- International Myeloma Working Group
- Health Care Expenditure
- Diagnosis Criteria
- BET Bromodomains
- Generic Drugs
- Quality of Life
- Cost-effectiveness Analysis
- Drug Development Costs
- Ageing Population
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- Healthcare Policy
- JAK2 Mutation
- PROTACs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cost-effectiveness Analysis31 topic
- Quality of Life31 topic
- Drug Development Costs21 topic
- Generic Drugs21 topic
- Ageing Population11 topic
- BET Bromodomains11 topic
- Chronic Lymphocytic Leukemia11 topic
- Diagnosis Criteria11 topic
- Genomic Aberrations11 topic
- Health Care Expenditure11 topic
- Healthcare Policy11 topic
- International Myeloma Working Group11 topic
- JAK2 Mutation11 topic
- Myelofibrosis11 topic
- PROTACs11 topic
- Public Health11 topic
Where does István Májer work?
István Májer's main affiliation in the publication record is Amgen (United States), United States.
How many publications and citations does István Májer have?
Science Explorer counts 15 works and 19 citations for István Májer, ranking #1,103,506 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.